BUY 5364 min ago
Issued: 22 sep 2022 @ 15:56
Previous signal: 2022-09-22 19:32:47
Previous signal status:
Return: 0.43 %
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need...
Market Cap: 902 525 M
ATR(14 days): $0.142 (0.41%)
The live signals presented on this page help determine when to BUY or SELL Keros Therapeutics Inc. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.